Patient Descriptors Of Cancer-Related Fatigue: A Mixed Methods Pilot Study Of Cancer Survivors
VAP
2 other identifiers
observational
80
1 country
3
Brief Summary
The purpose of this research study is to better understand how cancer-related fatigue affects patients and how it's discussed with providers. This information will be used to develop an educational resource (visual aid poster) that could help individuals and their providers talk about cancer-related fatigue and which may help individuals better manage this symptom.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2025
Typical duration for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 7, 2024
CompletedFirst Posted
Study publicly available on registry
October 9, 2024
CompletedStudy Start
First participant enrolled
March 12, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2028
February 2, 2026
January 1, 2026
3.2 years
October 7, 2024
January 30, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Domains reflecting cancer-related fatigue (CRF) experiences in cancer survivors
A domain is a topic that people talk about that has sub-items characterizing the distinct features and levels of importance within the domain. Using qualitative analysis, evaluation of how survivors think and talk about CRF to generate domain classifications of language. Domain is a categorical variable.
Seven months from baseline
Secondary Outcomes (3)
Qualitative themes derived from open-ended interviews of clinicians
Five months from screening
Domains reflecting CRF experiences in cancer survivors
Seven months from baseline
Appropriateness of the visual aid to alleviate survivor-clinician communication barriers
Eleven months from baseline
Study Arms (2)
Survivors
Cancer survivors with any type of cancer and a history of at least 1 visit for the purpose of monitoring long term care post curative treatment at LCH and/or the Charlotte or Winston-Salem campuses of AHWFBCCC who have completed curative treatment for more than 6 months.
Clinicians
Any providers working with post-treatment oncology survivors at LCH and the Charlotte or Winston Salem campuses of AHWFBCCC.
Interventions
After all qualitative interviews and associated quantitative data analysis are complete, the visual aid will be created to illustrate, through a type of Venn Diagram, how the data are related.
Eligibility Criteria
Cancer survivors and clinicians at LCH and/or at the Charlotte or Winston-Salem campuses of AHWFBCCC.
You may qualify if:
- Ability to comply with study procedures for the duration of the study
- Survivors:
- Written informed consent and HIPAA authorization for release of personal information
- Ability to read/write, understand and converse in English without the need for an interpreter
- Men and women aged ≥ 18 years at the time of consent
- White or Caucasian, Black or African American, or Hispanic or Latino/a
- History of at least one visit for the purpose of monitoring long term care post curative treatment at LCH and/or the Charlotte or Winston-Salem campuses of AHWFBCCC
- Completed curative treatment \> 6 months ago for any cancer type, with no detectable evidence of cancer
- Self-reported fatigue score of ≥ 4 on the Numerical Rating Scale
- Clinicians:
- \- Currently see oncology patients (any cancer type) for survivorship care at LCH and/or the Charlotte or Winston-Salem campuses of AHWFBCCC
You may not qualify if:
- Survivors:
- Continuing maintenance therapy or other cancer-related treatment (i.e. immunotherapy or hormonal therapy)
- History of or current severe or untreated depression
- Hemoglobin \<11g/dL at last CBC SOC lab collection
- History/diagnosis of dementia
- Factors or conditions, for which participation may (1) not be in the best interest or (2) interfere with study assessment results (e.g. medical comorbidities, primary brain tumor/metastases)
- No access to internet/Wi-Fi
- Clinicians:
- \- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (3)
Levine Childrens Hospital Pediatric Cancer and Blood Disorders
Charlotte, North Carolina, 28203, United States
Levine Cancer Institute
Charlotte, North Carolina, 28204, United States
Wake Forest Baptist Comprehensive Cancer Center
Winston-Salem, North Carolina, 27157, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dori Beeler, PhD
Atrium Health Wake Forest Baptist Comprehensive Cancer Center
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 7, 2024
First Posted
October 9, 2024
Study Start
March 12, 2025
Primary Completion (Estimated)
June 1, 2028
Study Completion (Estimated)
June 1, 2028
Last Updated
February 2, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share